Skip to main content
logo
Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
3.790
-0.040 (-1.04%)
Nov 3, 2026, 3:09 PM EST - Market open

Recursion Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
2,2662,1292,6662,1361,4612,895
Market Cap Growth
-6.09%-20.16%24.83%46.15%-49.52%-
Enterprise Value
1,7911,5512,3291,8001,0592,317
Last Close Price
3.834.096.769.867.7117.13

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
33.9128.5045.3247.9236.68284.42
PB Ratio
2.301.882.584.613.015.33
P/TBV Ratio
4.913.234.855.703.025.35

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
26.9420.7739.5940.3826.58227.62

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.080.070.110.110.110.00
Net Debt / Equity Ratio
-0.52-0.59-0.47-0.74-1.03-0.95
Net Debt / EBITDA Ratio
1.111.181.101.052.132.96
Net Debt / FCF Ratio
1.521.761.301.144.142.60
Asset Turnover
0.050.050.060.070.060.02
Quick Ratio
4.755.203.434.245.5111.27
Current Ratio
5.015.503.814.705.6811.46
Return on Equity (ROE)
-48.72%-59.54%-61.90%-69.12%-46.56%-47.51%
Return on Assets (ROA)
-23.89%-27.72%-28.48%-32.29%-23.42%-25.14%
Return on Capital Employed (ROCE)
-45.60%-48.90%-38.00%-62.50%-40.90%-32.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-23.60%-30.29%-17.39%-15.36%-16.39%-6.44%
FCF Yield
-13.51%-17.77%-13.98%-14.03%-8.25%-6.85%
Buyback Yield / Dilution
-32.62%-63.18%-31.92%-18.41%-40.04%-475.48%
SEC Filings: 10-K · 10-Q